Related Experiment Video
Updated: Jan 23, 2026

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment
Published on: June 9, 2023
let-7i inhibits proliferation and migration of bladder cancer cells by targeting HMGA1
1Clinical Laboratory, The First Affiliated Hospital of Wannan Medical College, No.2, West Zheshan Road, Wuhu, 241001, Anhui, China.
Background:
Let-7 is one of the earliest discovered microRNAs(miRNAs) and has been reported to be down-regulated in multiple malignant tumors. The effects and molecular mechanisms of let-7i in bladder cancer are still unclear. This study was to investigate the effects and potential mechanisms of let-7i on bladder cancer cells.
Methods:
Total RNA was extracted from bladder cancer cell lines. The expression levels of let-7i and HMGA1 were examined by quantitative real-time PCR. Cell viability was detected using the CCK-8 and colony formation assays, while transwell and wound healing assays were used to evaluate migration ability. Luciferase reporter assay and western blot were used to confirm the target gene of let-7i.
Results:
Compared with the SV-40 immortalized human uroepithelial cell line (SV-HUC-1), bladder cancer cell lines T24 and 5637 had low levels of let-7i expression, but high levels of high mobility group protein A1 (HMGA1) expression. Transfection of cell lines T24 and 5637 with let-7i mimic suppressed cell proliferation and migration. Luciferase reporter assay confirmed HMGA1 may be one of the target genes of let-7i-5p. Protein and mRNA expression of HMGA1 was significantly downregulated in let-7i mimic transfected cell lines T24 and 5637.
Conclusions:
Up-regulation of let-7i suppressed proliferation and migration of the human bladder cancer cell lines T24 and 5637 by targeting HMGA1. These findings suggest that let-7i might be considered as a novel therapeutic target for bladder cancer.
Insights
The microRNA let-7i suppresses bladder cancer cell growth and migration by targeting HMGA1. This suggests let-7i is a potential therapeutic target for bladder cancer treatment.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Let-7 microRNAs (miRNAs) are downregulated in various cancers.
- The role of let-7i in bladder cancer remains largely unknown.
- Investigating let-7i's function and mechanisms in bladder cancer is crucial.
Purpose of the Study:
- To explore the effects of let-7i on bladder cancer cell lines.
- To elucidate the molecular mechanisms underlying let-7i's action in bladder cancer.
- To identify potential therapeutic targets for bladder cancer.
Main Methods:
- Quantitative real-time PCR to measure let-7i and HMGA1 expression.
- Cell viability assays (CCK-8, colony formation) to assess proliferation.
- Transwell and wound healing assays for migration.
- Luciferase reporter and Western blot assays to confirm target gene.
Main Results:
- Bladder cancer cell lines (T24, 5637) exhibited low let-7i and high HMGA1 expression compared to normal uroepithelial cells (SV-HUC-1).
- let-7i mimic transfection inhibited proliferation and migration in T24 and 5637 cells.
- HMGA1 was confirmed as a target gene, with its mRNA and protein levels downregulated by let-7i.
Conclusions:
- let-7i upregulation inhibits bladder cancer cell proliferation and migration.
- HMGA1 is a direct target of let-7i in bladder cancer.
- let-7i represents a promising therapeutic target for bladder cancer.
Related Concept Videos
Cancer Cell Migration through Invadopodia
Targeted Cancer Therapies
There are several types of targeted therapies against...
Cell Migration
Cell Migration
Feedback Inhibition
Cells Coordinate Growth and Proliferation

